BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21855267)

  • 1. Magnetic resonance for assessment of axillary lymph node status in early breast cancer: a systematic review and meta-analysis.
    Harnan SE; Cooper KL; Meng Y; Ward SE; Fitzgerald P; Papaioannou D; Ingram C; Lorenz E; Wilkinson ID; Wyld L
    Eur J Surg Oncol; 2011 Nov; 37(11):928-36. PubMed ID: 21855267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.
    Liang X; Yu J; Wen B; Xie J; Cai Q; Yang Q
    Clin Radiol; 2017 Apr; 72(4):295-301. PubMed ID: 28139203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
    Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.
    Cooper KL; Harnan S; Meng Y; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Eur J Surg Oncol; 2011 Mar; 37(3):187-98. PubMed ID: 21269795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lymph node metastases by gadolinium-enhanced magnetic resonance imaging: systematic review and meta-analysis.
    Klerkx WM; Bax L; Veldhuis WB; Heintz AP; Mali WP; Peeters PH; Moons KG
    J Natl Cancer Inst; 2010 Feb; 102(4):244-53. PubMed ID: 20124189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
    Meng Y; Ward S; Cooper K; Harnan S; Wyld L
    Eur J Surg Oncol; 2011 Jan; 37(1):40-6. PubMed ID: 21115232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis.
    Wu L; Cao Y; Liao C; Huang J; Gao F
    Eur J Radiol; 2011 Nov; 80(2):582-9. PubMed ID: 20047813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
    Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
    Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO.
    Stets C; Brandt S; Wallis F; Buchmann J; Gilbert FJ; Heywang-Köbrunner SH
    J Magn Reson Imaging; 2002 Jul; 16(1):60-8. PubMed ID: 12112504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time MRI navigated US: role in diagnosis and guided biopsy of incidental breast lesions and axillary lymph nodes detected on breast MRI but not on second look US.
    Pons EP; Azcón FM; Casas MC; Meca SM; Espona JLG
    Eur J Radiol; 2014 Jun; 83(6):942-950. PubMed ID: 24725672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer.
    Motomura K; Izumi T; Tateishi S; Tamaki Y; Ito Y; Horinouchi T; Nakanishi K
    Br J Surg; 2016 Jan; 103(1):60-9. PubMed ID: 26572241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
    Yeung DK; Yang WT; Tse GM
    Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
    Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
    BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.